266 related articles for article (PubMed ID: 35459935)
21. Boosting NAD
Gardell SJ; Hopf M; Khan A; Dispagna M; Hampton Sessions E; Falter R; Kapoor N; Brooks J; Culver J; Petucci C; Ma CT; Cohen SE; Tanaka J; Burgos ES; Hirschi JS; Smith SR; Sergienko E; Pinkerton AB
Nat Commun; 2019 Jul; 10(1):3241. PubMed ID: 31324777
[TBL] [Abstract][Full Text] [Related]
22. Targeting the NAD
Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
[TBL] [Abstract][Full Text] [Related]
23. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms.
Zhang XQ; Lu JT; Jiang WX; Lu YB; Wu M; Wei EQ; Zhang WP; Tang C
Neuroscience; 2015 Apr; 291():230-40. PubMed ID: 25684751
[TBL] [Abstract][Full Text] [Related]
24. The Depletion of NAMPT Disturbs Mitochondrial Homeostasis and Causes Neuronal Degeneration in Mouse Hippocampus.
Shen C; Chen C; Wang T; Gao TY; Zeng M; Lu YB; Zhang WP
Mol Neurobiol; 2023 Mar; 60(3):1267-1280. PubMed ID: 36441480
[TBL] [Abstract][Full Text] [Related]
25. SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.
Sociali G; Grozio A; Caffa I; Schuster S; Becherini P; Damonte P; Sturla L; Fresia C; Passalacqua M; Mazzola F; Raffaelli N; Garten A; Kiess W; Cea M; Nencioni A; Bruzzone S
FASEB J; 2019 Mar; 33(3):3704-3717. PubMed ID: 30514106
[TBL] [Abstract][Full Text] [Related]
26. Tripeptide IRW Upregulates NAMPT Protein Levels in Cells and Obese C57BL/6J Mice.
Bhullar KS; Son M; Kerek E; Cromwell CR; Wingert BM; Wu K; Jovel J; Camacho CJ; Hubbard BP; Wu J
J Agric Food Chem; 2021 Feb; 69(5):1555-1566. PubMed ID: 33522796
[TBL] [Abstract][Full Text] [Related]
27. SIRT1 selectively exerts the metabolic protective effects of hepatocyte nicotinamide phosphoribosyltransferase.
Higgins CB; Mayer AL; Zhang Y; Franczyk M; Ballentine S; Yoshino J; DeBosch BJ
Nat Commun; 2022 Feb; 13(1):1074. PubMed ID: 35228549
[TBL] [Abstract][Full Text] [Related]
28. Restoring NAD
Katayoshi T; Nakajo T; Tsuji-Naito K
J Photochem Photobiol B; 2021 Aug; 221():112238. PubMed ID: 34130091
[TBL] [Abstract][Full Text] [Related]
29. The NAD(+) salvage pathway modulates cancer cell viability via p73.
Sharif T; Ahn DG; Liu RZ; Pringle E; Martell E; Dai C; Nunokawa A; Kwak M; Clements D; Murphy JP; Dean C; Marcato P; McCormick C; Godbout R; Gujar SA; Lee PW
Cell Death Differ; 2016 Apr; 23(4):669-80. PubMed ID: 26586573
[TBL] [Abstract][Full Text] [Related]
30. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD
Grolla AA; Miggiano R; Di Marino D; Bianchi M; Gori A; Orsomando G; Gaudino F; Galli U; Del Grosso E; Mazzola F; Angeletti C; Guarneri M; Torretta S; Calabrò M; Boumya S; Fan X; Colombo G; Travelli C; Rocchio F; Aronica E; Wohlschlegel JA; Deaglio S; Rizzi M; Genazzani AA; Garavaglia S
J Biol Chem; 2020 Mar; 295(11):3635-3651. PubMed ID: 31988240
[TBL] [Abstract][Full Text] [Related]
31. Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase.
Zabka TS; Singh J; Dhawan P; Liederer BM; Oeh J; Kauss MA; Xiao Y; Zak M; Lin T; McCray B; La N; Nguyen T; Beyer J; Farman C; Uppal H; Dragovich PS; O'Brien T; Sampath D; Misner DL
Toxicol Sci; 2015 Mar; 144(1):163-72. PubMed ID: 25505128
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer.
Ju HQ; Zhuang ZN; Li H; Tian T; Lu YX; Fan XQ; Zhou HJ; Mo HY; Sheng H; Chiao PJ; Xu RH
Cancer Lett; 2016 Aug; 379(1):1-11. PubMed ID: 27233476
[TBL] [Abstract][Full Text] [Related]
34. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.
O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D
Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854
[TBL] [Abstract][Full Text] [Related]
35. Discovery of Dual Function Agents That Exhibit Anticancer Activity via Catastrophic Nicotinamide Adenine Dinucleotide Depletion.
Fu Y; Huang Y; Zhou C; Li X; Dong G; Huang M; Ding J; Sheng C
J Med Chem; 2023 Dec; 66(24):16694-16703. PubMed ID: 38060985
[TBL] [Abstract][Full Text] [Related]
36. Subcellular NAMPT-mediated NAD
Wang X; Zhang Z; Zhang N; Li H; Zhang L; Baines CP; Ding S
J Neurochem; 2019 Dec; 151(6):732-748. PubMed ID: 31553812
[TBL] [Abstract][Full Text] [Related]
37. Discovery of proqodine A derivatives with antitumor activity targeting NAD(P)H: quinone oxidoreductase 1 and nicotinamide phosphoribosyltransferase.
Song J; Zou G; Zhao Z; Zhu Y; Xue J; Ao L; Sun H; Hao H; Zhang B; Xu X
Chin J Nat Med; 2024 Jan; 22(1):75-88. PubMed ID: 38278561
[TBL] [Abstract][Full Text] [Related]
38. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.
Hsu CP; Oka S; Shao D; Hariharan N; Sadoshima J
Circ Res; 2009 Aug; 105(5):481-91. PubMed ID: 19661458
[TBL] [Abstract][Full Text] [Related]
39. Nicotinamide phosphoribosyltransferase‑related signaling pathway in early Alzheimer's disease mouse models.
Xing S; Hu Y; Huang X; Shen D; Chen C
Mol Med Rep; 2019 Dec; 20(6):5163-5171. PubMed ID: 31702813
[TBL] [Abstract][Full Text] [Related]
40. Perturbations of NAD
Agerholm M; Dall M; Jensen BAH; Prats C; Madsen S; Basse AL; Graae AS; Risis S; Goldenbaum J; Quistorff B; Larsen S; Vienberg SG; Treebak JT
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E377-E395. PubMed ID: 29208611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
